| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H2010 |
Comprehensive medication services, per 15 minutes |
384,957 |
21,325 |
$2.95M |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
41,243 |
20,316 |
$2.09M |
| H0031 |
Mental health assessment, by non-physician |
6,110 |
5,742 |
$808K |
| T1003 |
Lpn/lvn services, up to 15 minutes |
53,091 |
28,471 |
$597K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,646 |
8,543 |
$583K |
| S0215 |
Non-emergency transportation; mileage, per mile |
39,809 |
4,165 |
$579K |
| H0038 |
Self-help/peer services, per 15 minutes |
17,674 |
9,580 |
$489K |
| T1016 |
Case management, each 15 minutes |
27,037 |
17,036 |
$476K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
22,410 |
12,611 |
$445K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
2,638 |
1,693 |
$367K |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
95,648 |
11,473 |
$338K |
| A0120 |
Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems |
37,095 |
4,023 |
$249K |
| 82075 |
|
21,553 |
9,463 |
$180K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,868 |
1,698 |
$113K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,718 |
2,694 |
$83K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
306 |
50 |
$50K |
| T1002 |
Rn services, up to 15 minutes |
4,457 |
3,234 |
$35K |
| 99205 |
Prolong outpt/office vis |
397 |
353 |
$28K |
| A0110 |
Non-emergency transportation and bus, intra or inter state carrier |
864 |
656 |
$17K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
974 |
910 |
$14K |
| 81025 |
|
4,643 |
2,708 |
$14K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
71 |
65 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
90 |
66 |
$5K |
| H2016 |
Comprehensive community support services, per diem |
19 |
12 |
$3K |
| 86580 |
|
1,063 |
778 |
$3K |
| 80305 |
|
5,027 |
3,076 |
$2K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
13 |
12 |
$2K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$611.35 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
56 |
$296.01 |
| 36415 |
Collection of venous blood by venipuncture |
67 |
54 |
$96.83 |
| 80100 |
|
344 |
93 |
$0.00 |
| 86592 |
|
20 |
12 |
$0.00 |
| 80102 |
|
71 |
42 |
$0.00 |